# OnCo record nct05725200 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05725200/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05725200", "NCT05725200" ;
  schema:name "Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer"@en ;
  schema:description "A phase 2 trial of Patient-derived organoids in Colorectal cancer, run by Oslo University Hospital, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05725200/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05725200> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/organoids/> ;
  onco:drugs <https://onco.cc/drugs/alectinib/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/crizotinib/>, <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/encorafenib/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/idelalisib/>, <https://onco.cc/drugs/larotrectinib/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/panobinostat/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/talazoparib/>, <https://onco.cc/drugs/venetoclax/> .